Literature DB >> 10215098

The cellular localization of the L-ornithine decarboxylase/polyamine system in normal and diseased central nervous systems.

H G Bernstein1, M Müller.   

Abstract

Natural polyamines, spermidine and spermine, and their precursor putrescine, are of considerable importance for the developing and mature nervous system. They exhibit a number of neurophysiological and metabolic effects in the nervous system, including control of nucleic acid and protein synthesis, modulation of ionic channels and calcium-dependent transmitter release. The polyamine system is also known to be involved in various brain pathologic events (seizures, stroke, Alzheimer's disease and others). While cerebral polyamine concentrations and the activities of polyamine-metabolizing enzymes have been studied in great detail, much less is known about the cells that are responsible for cerebral polyamine synthesis and interconversion. With the present review the attempt is made to show how exact knowledge about the regional distribution and cellular localization of polyamines and the polyamine-synthesizing enzymatic machinery (and especially of L-ornithine decarboxylase) may help to better understand the functional interplay between polyamines and other endogenous agents (transmitters, receptors, growth factors neuroactive drugs etc.). Polyamines have been localized both in neurones and glial cells. However, the main cellular locus of the ODC is the neuron--both in the immature and adult central nervous system. Each period of normal brain development and ageing seems to have its own, characteristic temporo-spatial pattern of neuronal ODC expression. During strong functional activation (kindling, epileptic seizures, neural transplantation) astrocytes and other non-neuronal cells do also express ODC and other polyamine-metabolizing enzymes. Astroglial expression of ODC is accompanied by an increase in glial fibrillary acidic protein in these cells. This shift in the cellular mechanisms of polyamine metabolism is currently far from being understood. In human brain diseases (Alzheimer's disease, schizophrenia) certain neurones show an increased expression of ODC, the first and rate-limiting enzyme of polyamine metabolism. Since polyamines are structurally related to psychoactive drugs (neuroleptics, antidepressants) the polyamine system might be of importance as a putative target for drug intervention in psychiatry.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215098     DOI: 10.1016/s0301-0082(98)00065-3

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  26 in total

1.  Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Authors:  Frank A Middleton; Karoly Mirnics; Joseph N Pierri; David A Lewis; Pat Levitt
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 2.  Polyamines in mammalian pathophysiology.

Authors:  Francisca Sánchez-Jiménez; Miguel Ángel Medina; Lorena Villalobos-Rueda; José Luis Urdiales
Journal:  Cell Mol Life Sci       Date:  2019-06-21       Impact factor: 9.261

Review 3.  Oxidation of polyamines and brain injury.

Authors:  N Seiler
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 4.  The role of glia in stress: polyamines and brain disorders.

Authors:  Serguei N Skatchkov; Michel A Woodbury-Fariña; Misty Eaton
Journal:  Psychiatr Clin North Am       Date:  2014-11-25

5.  Alterations in neuronal metabolism contribute to the pathogenesis of prion disease.

Authors:  Julie-Myrtille Bourgognon; Jereme G Spiers; Hannah Scheiblich; Alexey Antonov; Sophie J Bradley; Andrew B Tobin; Joern R Steinert
Journal:  Cell Death Differ       Date:  2018-06-18       Impact factor: 15.828

6.  LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent.

Authors:  Shweta S Puntambekar; Deirdre S Davis; Leo Hawel; Janelle Crane; Craig V Byus; Monica J Carson
Journal:  Brain Behav Immun       Date:  2011-01-13       Impact factor: 7.217

Review 7.  Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling.

Authors:  Elizabeth C M de Lange; Paulien G M Ravenstijn; Dorien Groenendaal; Tamara J van Steeg
Journal:  AAPS J       Date:  2005-10-07       Impact factor: 4.009

8.  Ornithine decarboxylase, the rate-limiting enzyme of polyamine synthesis, modifies brain pathology in a mouse model of tuberous sclerosis complex.

Authors:  David Kapfhamer; James McKenna; Caroline J Yoon; Tracy Murray-Stewart; Robert A Casero; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 9.  Implication of the polyamine system in mental disorders.

Authors:  Laura M Fiori; Gustavo Turecki
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

10.  Niemann-Pick C1 functions in regulating lysosomal amine content.

Authors:  Allyn M Kaufmann; Jeffrey P Krise
Journal:  J Biol Chem       Date:  2008-06-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.